| P2093 | author name string | Maryam Maghsoodi | |
| P2860 | cites work | Single crystal structure, solid state characterization and dissolution rate of terbinafine hydrochloride. | Q30597220 |
| | Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract | Q34190317 |
| | Crystalline solids | Q34233888 |
| | Crystal structures of drugs: advances in determination, prediction and engineering | Q35621381 |
| | Drug polymorphism and dosage form design: a practical perspective | Q35666935 |
| | Surface characterization: understanding sources of variability in the production and use of pharmaceuticals | Q40550593 |
| | Crystal habit modifications of ibuprofen and their physicomechanical characteristics | Q43793117 |
| | Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method | Q43824726 |
| | Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets | Q43850616 |
| | Crystal modification of phenytoin using different solvents and crystallization conditions. | Q44247738 |
| | Manipulation of powder characteristics by interactions at the solid-liquid interface: 1-sulphadiazine. | Q46550239 |
| | Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique | Q46867077 |
| | Influence of cohesive properties of micronized drug powders on particle size analysis | Q47358974 |
| | The effects of milling on the surface properties of form I paracetamol crystals. | Q51161567 |
| | Modification of crystal habit and its role in dosage form performance. | Q52052125 |
| | Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. | Q52132105 |
| | In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms. | Q52676357 |
| | Direct preparation of spherically agglomerated salicylic acid crystals during crystallization | Q70738371 |
| | New polymorphic forms of phenobarbital | Q70765176 |
| | Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate | Q72243313 |
| | Improved dissolution behavior of fenbufen by spherical crystallization | Q73102792 |
| | Highly compressible paracetamol - II. Compression properties | Q73154676 |
| | Ibuprofen agglomerates preparation by phase separation | Q74594521 |
| | Micronization: a method of improving the bioavailability of poorly soluble drugs | Q74727268 |
| | Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen | Q77756713 |
| | Crystal modification of dipyridamole using different solvents and crystallization conditions | Q79912662 |
| | Spherical crystallization: direct spherical agglomeration of salicylic Acid crystals during crystallization | Q81108602 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13-18 | |
| P577 | publication date | 2015-03-05 | |
| P1433 | published in | Advanced Pharmaceutical Bulletin | Q26853868 |
| P1476 | title | Role of solvents in improvement of dissolution rate of drugs: crystal habit and crystal agglomeration | |
| P478 | volume | 5 | |